Breast Unit, Department of Surgical Science, PTV Policlinico Tor Vergata University, Rome, Italy.
Breast Unit, Department of Surgical Science, PTV Policlinico Tor Vergata University, Rome, Italy;
Anticancer Res. 2022 Oct;42(10):4913-4919. doi: 10.21873/anticanres.15997.
BACKGROUND/AIM: SARS-CoV-2 with a dramatical worldwide spread, impacted greatly daily life and healthcare. In order to avoid delay in cancer treatment, many strategies and measures were implemented. The Awake breast surgery was a strategy implemented in our Unit during the pandemic, aimed to reduce operatory room occupancy and increase the number of procedures performed during the daily surgical session. The aim of the study was to evaluate how the use of this strategy has changed before and after the advent of the COVID-19 pandemic, and its relative benefits.
This was a retrospective study analysing all patients subjected to breast conservative surgery for oncological disease from July 2018 to December 2021.
Out of 498 patients enrolled in the study, 253 (50.8%) cases were treated before the pandemic and were designated as "pre-COVID-19" group. The remaining 245 (49.1%) cases were considered the "COVID-19" group. Cases of awake surgery in COVID-19 group were 141 (54.7%) vs. 84 (33.2%), p<0.001. Length of hospitalization and surgical time were comparable between the groups: relative p=0.188 and 0.264, respectively. Differently, operation room occupation was significantly shorter in the COVID-19 group, p<0.001; and number of outpatient surgical procedures was higher, p=0.0304. Multivariate analysis identified the period of surgery (OR=1.47) as a statistically significant factor, p=0.011, predictive of prolonged operatory room occupancy.
Awake surgery was one of the strategies which made more operating rooms available and allowed avoiding further delays.
背景/目的：SARS-CoV-2 在全球范围内迅速传播，极大地影响了日常生活和医疗保健。为了避免癌症治疗的延误，我们实施了许多策略和措施。清醒乳房手术是我们科室在疫情期间实施的一项策略，旨在减少手术室占用率并增加日常手术期间的手术次数。本研究的目的是评估在 COVID-19 大流行前后，这种策略的使用如何发生变化，以及其相对益处。
这是一项回顾性研究，分析了 2018 年 7 月至 2021 年 12 月期间因肿瘤疾病接受保乳手术的所有患者。
在纳入研究的 498 名患者中，253 例（50.8%）在大流行前接受治疗，被指定为“COVID-19 前”组。其余 245 例（49.1%）被认为是“COVID-19”组。COVID-19 组中清醒手术的病例为 141 例（54.7%），而 84 例（33.2%），p<0.001。两组之间的住院时间和手术时间无差异：相对 p=0.188 和 0.264。不同的是，COVID-19 组的手术室占用时间明显缩短，p<0.001；门诊手术次数较高，p=0.0304。多变量分析确定手术期间（OR=1.47）为具有统计学意义的因素，p=0.011，可预测手术室占用时间延长。
清醒手术是增加手术室可用性并避免进一步延误的策略之一。
